Peter Hildebrandt is an experienced executive and strategic advisor with a diverse background in leadership roles across various sectors. Currently serving as Interim CEO and Chairman of the Board at FRAMA since February 2018, Peter also founded Panopticon Capital in March 2024 and has been the owner of Panopticon Holding since January 2007, focusing on IT, Biotech, and Synthetic Biology. Notable past positions include Portfolio Manager at Advice Capital, overseeing a biotech fund, and strategic advisor at Hildebrandt Consulting. Peter has held board positions in multiple organizations, including Advisory Capital Vision Fund A/S and GLX Analytix. An alumnus of the University of Copenhagen, Peter holds a degree in politics and law, complemented by prior education in Math and Philosophy.
This person is not in the org chart
This person is not in any teams
This person is not in any offices